Aristotle University Of Thessaloniki (AUTH)
Μελέτη των αγγειογενετικών παραγόντων σε ασθενείς με αιμορροφιλία
Abstract
dc:descriptionIn the present study an attempt was made to approach angiogenesis, which occurred in patients with hemophilia and arthropathy, through the study of various angiogenetic factors. In the study, a total of 77 participants, 55 patients with hemophilia and 22 healthy volunteers were studied. The mean age of the individuals in the two groups was 40 years. Angiogenic factors such as Vascular Endothelial Growth Factor (VEGF), Fibroblastic Growth Factor (FGF), Metalloproteinase -9 (MMP-9), and angiopoietins -1 and -2 (Ang-1- and Ang-2) were measured by ELISA method. Hemophilic arthropathy evaluation was based on the Petersson and Arnold-Hilgartner radiological criteria. Serum levels of VEGF and MMP-9 in the hemophilia patients in the study were lower than those in healthy controls. However, a statistically significant correlation was found between VEGF and MMP-9 levels. This finding reflects the interdependence of these factors in the process of angiogenesis. B-FGF levels in the hemophilia patients in the study were lower than those in healthy controls. Patients investigated in the present study showed elevated Ang-2 levels compared with healthy subjects, whereas Ang-1 levels in the hemophilia patients in the study were lower than those in healthy controls. Plasma Ang-1 levels were also found to be positively correlated with MMP-9 levels. In addition, plasma VEGF levels were positively correlated with Ang-1 levels. The study did not find statistically significant differences in the levels of angiogenic factors between patients with hemophilia A and B, possibly due to unequal distribution of the two groups. Also, no statistically significant correlations were found regarding the prophylactic treatment. The results of the values of angiogenic factors in the patients of the study based on the severity of the disease were interesting. Among the angiogenic factors, Angio-2 levels were found to be higher in patients with moderate and severe hemophilia compared with levels in patients with mild hemophilia. In addition, the correlation of angiogenic factors levels with the severity of hemophilic arthropathy, based on the Pettersson score (PS), showed that MMP-9 levels were higher in group 2 patients (PS ≤ 5) without a statistically significant correlation. Also, the levels of Angio-1 and VEGF were found higher in group 2 but without statistically significant correlation compared to the other groups. Angio-2 levels were found to be statistically significantly higher in group 3 patients (PS> 5), as were FGF levels but without statistically significant potency. In conclusion, we consider that angiogenetic process is observed in patients with hemophilic arthropathy as it is expressed by the increased levels of Ang-2 as well as the statistical correlations between VEGF, MMP-9 and Ang-1. The findings of the study are partly in line with those of the recent literature. The combination of serological markers (biomarkers) and imaging criteria may be a new useful tool for the early diagnosis of joint damage and may lead to the development of new therapies for the treatment of hemophilic arthropathy.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Agapidou, Alexandra
- Αγαπίδου, Αλεξάνδρα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51782